Want to create an interactive transcript for this episode?
Podcast: DirectorsTalk Interviews
Episode: Open Orphan CEO Cathal Fiel ‘Expect some quite substantial contracts’
Description: Open Orphan plc (LON:ORPH) CEO Cathal Friel joins DirectorsTalk to discuss the testing of an anti-viral for treating COVID-19. Cathal explains whats involved in the testing, the time frames involved and what investors should expect over the coming months and weeks. Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. It has Europe's only 24-bedroom quarantine clinic with onsite virology lab in Queen Mary's Hospital L...